文献速递慢病防控与筛查卫生政策与健康促进

利用处方药监测项目数据预测阿片类药物过量死亡

Predicting Opioid Overdose Deaths Using Prescription Drug Monitoring Program Data.
PubMed 文献 · Am J Prev Med · 2019-01-01

研究基于马里兰州2016年1至6月有阿片类药物处方的18-80岁居民(n=565,175),采用回顾性队列分析和分半技术开发并验证多变量逻辑回归模型,预测任何阿片类或非法阿片类药物致死性过量。验证队列模型区分度良好(曲线下面积:任何阿片类0.81;非法阿片类0.77)。

要点

  • 预测任何阿片类相关致死性过量的因素包括男性、65-80岁、医疗补助、医疗保险、长效阿片类药物配药≥1次等。
  • 模型在验证队列中区分度良好,任何阿片类致死性过量曲线下面积为0.81,非法阿片类为0.77。
  • 模型在识别非法阿片类和处方阿片类致死性过量风险方面表现相当。

核心结论

  • 利用处方药监测项目数据开发了预测致死性阿片类药物过量的模型。
  • 鉴于近期涉及海洛因和芬太尼的死亡全国性流行,值得注意的是该模型在识别非法阿片类和处方阿片类致死性过量风险方面表现相当。

研究设计与样本

  • 回顾性队列分析,纳入2016年1月至6月有阿片类药物处方的马里兰州18-80岁居民(n=565,175)。
  • 致死性阿片类药物过量从首席法医办公室识别,并与处方药监测项目数据在个人层面链接。
  • 采用分半技术开发并验证多变量逻辑回归模型,回顾期为6个月,并评估模型校准度和区分度。

主要发现

  • 任何阿片类相关致死性过量的预测因素包括男性、65-80岁、医疗补助、医疗保险、长效阿片类药物配药≥1次、丁丙诺啡配药≥1次、短效第二类阿片类药物配药2-3次和≥4次、阿片类药物供应天数≥91天、平均吗啡毫克当量日剂量、苯二氮䓬类药物配药≥2次、肌肉松弛剂配药≥1次。
  • 验证队列模型区分度良好(曲线下面积:任何阿片类0.81;非法阿片类0.77)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Prescription Drug Monitoring Program data can provide insights into a patient's likelihood of an opioid overdose, yet clinicians and public health officials lack indicators to identify individuals at highest risk accurately. A predictive model was developed and validated using Prescription Drug Monitoring Program prescription histories to identify those at risk for fatal overdose because of any opioid or illicit opioids. METHODS: From December 2018 to July 2019, a retrospective cohort analysis was performed on Maryland residents aged 18-80 years with a filled opioid prescription (n=565,175) from January to June 2016. Fatal opioid overdoses were identified from the Office of the Chief Medical Examiner and were linked at the person-level with Prescription Drug Monitoring Program data. Split-half technique was used to develop and validate a multivariate logistic regression with a 6-month lookback period and assessed model calibration and discrimination. RESULTS: Predictors of any opioid-related fatal overdose included male sex, age 65-80 years, Medicaid, Medicare, 1 or more long-acting opioid fills, 1 or more buprenorphine fills, 2 to 3 and 4 or more short-acting schedule II opioid fills, opioid days' supply ≥91 days, average morphine milligram equivalent daily dose, 2 or more benzodiazepine fills, and 1 or more muscle relaxant fills. Model discrimination for the validation cohort was good (area under the curve: any, 0.81; illicit, 0.77). CONCLUSIONS: A model for predicting fatal opioid overdoses was developed using Prescription Drug Monitoring Program data. Given the recent national epidemic of deaths involving heroin and fentanyl, it is noteworthy that the model performed equally well in identifying those at risk for overdose deaths from both illicit and prescription opioids.

来源:Am J Prev Med,查看原文。版权归原作者所有。

引用

  1. Ferris LM, Saloner B, Krawczyk N, et al. Predicting Opioid Overdose Deaths Using Prescription Drug Monitoring Program Data. Am J Prev Med. 2019. PMID: 31753274. doi:10.1016/j.amepre.2019.07.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。